Czech Republic: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Czech Republic

The Czech prophylactic medicaments containing insulin market dropped modestly to $X in 2022, flattening at the previous year. The market value increased at an average annual rate of +4.4% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Prophylactic medicaments containing insulin consumption peaked at $X in 2017; however, from 2018 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Czech Republic

In value terms, prophylactic medicaments containing insulin production fell to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +4.3% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The growth pace was the most rapid in 2013 when the production volume increased by 27%. Over the period under review, production reached the peak level at $X in 2016; however, from 2017 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the Czech Republic

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from the Czech Republic; waning by -24% against 2021 figures. Overall, exports, however, continue to indicate strong growth. The pace of growth appeared the most rapid in 2014 when exports increased by 105% against the previous year. The exports peaked at X tons in 2021, and then contracted significantly in the following year.

In value terms, prophylactic medicaments containing insulin exports dropped notably to $X in 2022. In general, exports, however, posted prominent growth. The pace of growth appeared the most rapid in 2014 with an increase of 127%. Over the period under review, the exports reached the peak figure at $X in 2021, and then declined rapidly in the following year.

Exports by Country

Denmark (X tons), the UK (X tons) and Slovakia (X tons) were the main destinations of prophylactic medicaments containing insulin exports from the Czech Republic, together accounting for 77% of total exports. Germany, the Netherlands, Ireland and Austria lagged somewhat behind, together comprising a further 20%.

From 2012 to 2022, the biggest increases were recorded for Austria (with a CAGR of +76.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X), the UK ($X) and Slovakia ($X) were the largest markets for prophylactic medicaments containing insulin exported from the Czech Republic worldwide, together comprising 77% of total exports. Germany, the Netherlands, Ireland and Austria lagged somewhat behind, together comprising a further 20%.

Austria, with a CAGR of +61.2%, saw the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, reducing by -2.7% against the previous year. Over the period under review, the export price showed a mild curtailment. The growth pace was the most rapid in 2013 when the average export price increased by 21% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2015; however, from 2016 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Slovakia ($X per ton), while the average price for exports to Austria ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (+1.8%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the Czech Republic

In 2022, overseas purchases of medicaments containing insulin but not antibiotics in measured doses decreased by -32.3% to X tons for the first time since 2014, thus ending a seven-year rising trend. Over the period under review, imports, however, continue to indicate a buoyant increase. The pace of growth was the most pronounced in 2013 with an increase of 48%. Over the period under review, imports reached the maximum at X tons in 2021, and then contracted notably in the following year.

In value terms, prophylactic medicaments containing insulin imports contracted dramatically to $X in 2022. Overall, imports, however, saw a relatively flat trend pattern. The growth pace was the most rapid in 2013 when imports increased by 15% against the previous year. Over the period under review, imports hit record highs at $X in 2021, and then dropped dramatically in the following year.

Imports by Country

Germany (X tons), Italy (X tons) and the United States (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to the Czech Republic, together comprising 58% of total imports. Denmark, France, Greece, China, Brazil, Romania, the Netherlands, Slovakia and Portugal lagged somewhat behind, together comprising a further 38%.

From 2012 to 2022, the biggest increases were recorded for Portugal (with a CAGR of +75.6%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), Italy ($X) and the United States ($X) constituted the largest prophylactic medicaments containing insulin suppliers to the Czech Republic, with a combined 59% share of total imports. Denmark, France, Brazil, Greece, Romania, China, Portugal, the Netherlands and Slovakia lagged somewhat behind, together comprising a further 37%.

In terms of the main suppliers, Portugal, with a CAGR of +60.0%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, which is down by -9.2% against the previous year. Overall, the import price continues to indicate a abrupt downturn. The most prominent rate of growth was recorded in 2014 an increase of 10%. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Brazil ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Greece (-3.2%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :